For other types of cancer, the number of exosomes expressing CD63+ and/or caveolin-1+ are significantly increased in the plasma of patients with melanoma compared to that in healthy individuals, a finding that exhibits a higher detection sensitivity than that of conventional biomarkers. Here, CD63 is linked to melanoma.